Broadridge Financial Solutions Inc
BR
$160.93
+0.59%
Broadridge Financial Solutions Inc is a leading provider of investor communication and technology-driven solutions to the financial services industry. The company is defined by its dominant position in investor communications and its core narrative of providing essential, recurring technology and operations services to banks, asset managers, and corporate issuers.…
BR
Broadridge Financial Solutions Inc
$160.93
Investment Opinion: Should I buy BR Today?
Based on a synthesis of the available data, the objective assessment for BR is Hold. The stock appears oversold technically, trading just 3.5% above its 52-week low, and its forward P/E of 15.7 suggests a more reasonable valuation if earnings estimates are met. However, the severe price momentum, leveraged balance sheet, and lack of a clear near-term catalyst warrant caution. Investors should wait for evidence of a trend reversal or improved fundamental stability before considering a new position.
Sign up to view all
BR 12-Month Price Forecast
The analysis indicates a conflicted picture. The stock is fundamentally sound with a strong market position and cash flow, but technically broken and leveraged. The base case of range-bound consolidation is most probable, pending a fundamental or technical catalyst.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Broadridge Financial Solutions Inc's 12-month outlook, with a consensus price target around $209.21 and implied upside of +30.0% versus the current price.
Average Target
$209.21
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$129 - $209
Analyst target range
No sufficient analyst coverage available. The provided data includes three analyst ratings actions from firms like DA Davidson, Needham, and JP Morgan, but it does not contain a consensus target price or a comprehensive ratings distribution summary required for this analysis.
Bulls vs Bears: BR Investment Factors
Broadridge presents a classic value vs. momentum conflict. The company possesses strong fundamental qualities like high ROE and robust cash flow, but the stock is mired in a severe technical downtrend with significant leverage. The current price near 52-week lows suggests oversold conditions, but a catalyst is needed for recovery.
Bullish
- Strong Free Cash Flow: Generates $1.36B TTM FCF, providing financial flexibility and supporting dividends.
- High Return on Equity: ROE of 31.6% indicates efficient use of shareholder capital.
- Dominant Market Position: Leading provider of essential, recurring services in financial communications.
- Reasonable Forward Valuation: Forward P/E of 15.7 is more attractive than trailing P/E of 33.9.
Bearish
- Severe Price Downtrend: Stock down over 30% in 6 months, severely underperforming the market.
- Leveraged Balance Sheet: Debt-to-equity ratio of 1.30 indicates significant financial leverage.
- Tight Liquidity Position: Current ratio of 0.98 suggests potential short-term liquidity concerns.
- Volatile Earnings: Net income declined from $374M to $285M in recent quarters.
BR Technical Analysis
The stock has been in a pronounced downtrend over the last six months, with the price declining from above $230 in October 2025 to approximately $162 by March 2026. This represents a significant drawdown, with the 6-month price change at -30.47% and a 1-year decline of -32.99%, severely underperforming the broader market as indicated by negative relative strength figures across all periods. Short-term performance remains weak, with the stock down 12.58% over the past month and 27.19% over the past three months, far exceeding the S&P 500's declines of -5.25% and -4.63%, respectively. The current price of $162.48 is near the bottom of its 52-week range of $156.94 to $271.91, sitting just 3.5% above the 52-week low, which suggests the stock is in an oversold territory from a price-range perspective.
Beta
0.98
0.98x market volatility
Max Drawdown
-41.0%
Largest decline past year
52-Week Range
$156-$272
Price range past year
Annual Return
-34.6%
Cumulative gain past year
| Period | BR Return | S&P 500 |
|---|---|---|
| 1m | -14.2% | -3.6% |
| 3m | -27.0% | -4.0% |
| 6m | -31.4% | -2.0% |
| 1y | -34.6% | +16.2% |
| ytd | -27.0% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BR Fundamental Analysis
Revenue growth has been positive, with the most recent quarterly revenue of $1.71 billion showing a 7.85% year-over-year increase. Profitability metrics are mixed; the net margin improved to 16.61% in the latest quarter from 8.96% a year prior, but quarterly net income has shown volatility, declining from $374.2 million in Q4 2025 to $284.6 million in Q2 2026. The company's financial health shows a debt-to-equity ratio of 1.30, indicating a leveraged balance sheet, but it maintains a strong trailing twelve-month free cash flow of $1.36 billion, providing solid cash generation. Operational efficiency is highlighted by a robust Return on Equity (ROE) of 31.62%, though the current ratio of 0.98 suggests potential tightness in short-term liquidity.
Quarterly Revenue
$1.7B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.27%
Latest Quarter
Free Cash Flow
$1.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BR Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 33.90, while the forward P/E is 15.70 based on estimated EPS. The forward P/E suggests a more reasonable valuation if earnings estimates are met. The Price-to-Sales (P/S) ratio is 4.13, and the Enterprise Value-to-Sales (EV/Sales) is 3.06. Data for direct peer comparison with industry averages is not available in the provided inputs.
PE
33.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~113x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.5x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is the stock's pronounced and persistent downtrend, with a 6-month decline of 30.5% and a 1-year decline of 33.0%. This severe underperformance relative to the S&P 500 (negative relative strength across all periods) indicates deep-seated market skepticism, potentially related to concerns over its leveraged balance sheet (debt-to-equity of 1.30) and tight short-term liquidity (current ratio of 0.98).
Operational risks include earnings volatility, as seen in the quarterly net income decline from $374.2M to $284.6M. While the company's business model provides recurring revenue, its high trailing P/E ratio of 33.9 makes it vulnerable to multiple compression if growth expectations falter. The lack of a clear consensus analyst target adds uncertainty to the near-term price direction.
FAQ
Key risks include: 1) Continued severe price downtrend and underperformance vs. the market. 2) A leveraged balance sheet with a debt-to-equity ratio of 1.30. 3) Tight short-term liquidity indicated by a current ratio of 0.98. 4) Volatility in quarterly net income, as seen in recent results. 5) Exposure to the financial services sector, which is sensitive to economic cycles.
The 12-month outlook presents a base case target range of $170 to $195, assuming the stock consolidates and trades on its forward earnings multiple. A bear case could see a retest of the 52-week low near $157, while a bull case recovery could push the stock toward $230. The probabilities are weighted 50% for the base case, with 25% each for bull and bear scenarios.
Valuation is mixed. The trailing P/E of 33.9 appears high, but the forward P/E of 15.7, based on estimated EPS of ~$13.50, suggests the stock may be fairly valued or slightly undervalued if those estimates are achieved. The Price-to-Sales ratio of 4.13 is also a factor to consider. The sharp price drop has improved the valuation from historical levels.
BR is a Hold, not a clear Buy at this moment. The stock is oversold and its forward P/E of 15.7 is reasonable, but the severe 30%+ price decline over six months and high debt load (D/E 1.30) present significant near-term risks. Investors should wait for a stabilization in price momentum or an improvement in the balance sheet before establishing a new position.
BR is more suitable for a long-term investment horizon. The company's strong market position and cash flow generation support a long-term thesis. However, the severe near-term technical damage and leverage mean the stock could remain volatile and may require significant time to recover. It is not recommended for short-term trading given its weak momentum and lack of a clear catalyst.